SEPTInvestingStart Free

ADCT 10-Q: SEC filing

ADC Therapeutics SA

Filed with the SEC on · accession 0001628280-26-072178

ADCT filed a 10-Q (quarterly report) with the SEC on Nov 9, 2026. ADC Therapeutics SA filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenues, expenses, and balance sheet data. The stock moved -7.6% by the first close after the filing.

Summary of the filing

ADC Therapeutics SA filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenues, expenses, and balance sheet data. The filing contains standard XBRL financial data tags with no single material corporate event disclosed.

For details, click here →How to read a 10-Q →

Key details

FilerADC Therapeutics SA

How ADCT stock reacted

Close before

$1.58

Nov 6, 2026

First close after

-7.59%

$1.46

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ADCT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ADCT?

Click here

Frequently asked questions

What did ADCT file with the SEC on Nov 9, 2026?

ADCT filed a 10-Q (SEC filing). ADC Therapeutics SA filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results including revenues, expenses, and balance sheet data. The filing contains standard XBRL financial data tags with no single material corporate event disclosed.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did ADCT stock react to this filing?

ADCT closed at $1.58 before the filing and $1.46 on Nov 9, 2026 (-7.59%).

Other ADCT SEC filings

Get alerts when ADCT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ADCT overviewADCT analysisADCT newsLatest SEC filings